PROPYLTHIOURACIL AND METHIMAZOLE DISPLAY CONTRASTING PATHWAYS OF PERIPHERAL METABOLISM IN BOTH RAT AND HUMAN

被引:15
作者
TAUROG, A
DORRIS, ML
机构
关键词
D O I
10.1210/endo-122-2-592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:592 / 601
页数:10
相关论文
共 27 条
[1]   METABOLISM OF 35S-LABELLED ANTITHYROID DRUGS IN MAN [J].
ALEXANDER, WD ;
EVANS, V ;
MACAULAY, A ;
GALLAGHER, TF ;
LONDONO, J .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 2 (5652) :290-+
[2]   ANTITHYROID DRUGS [J].
COOPER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1353-1362
[3]   IRREVERSIBLE INACTIVATION OF THYROID PEROXIDASE BY METHYLMERCAPTOIMIDAZOLE, THIOURACIL, AND PROPYLTHIOURACIL INVITRO AND ITS RELATIONSHIP TO INVIVO FINDINGS [J].
DAVIDSON, B ;
SOODAK, M ;
NEARY, JT ;
STROUT, HV ;
KIEFFER, JD ;
MOVER, H ;
MALOOF, F .
ENDOCRINOLOGY, 1978, 103 (03) :871-882
[4]   MECHANISM OF INACTIVATION OF THYROID PEROXIDASE BY THIOUREYLENE DRUGS [J].
ENGLER, H ;
TAUROG, A ;
NAKASHIMA, T .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (23) :3801-3806
[5]   PREFERENTIAL INHIBITION OF THYROXINE AND 3,5,3'-TRIIODOTHYRONINE FORMATION BY PROPYLTHIOURACIL AND METHYLMERCAPTOIMIDAZOLE IN THYROID PEROXIDASE-CATALYZED IODINATION OF THYROGLOBULIN [J].
ENGLER, H ;
TAUROG, A ;
DORRIS, ML .
ENDOCRINOLOGY, 1982, 110 (01) :190-197
[6]   REVERSIBLE AND IRREVERSIBLE INHIBITION OF THYROID PEROXIDASE-CATALYZED IODINATION BY THIOUREYLENE DRUGS [J].
ENGLER, H ;
TAUROG, A ;
LUTHY, C ;
DORRIS, ML .
ENDOCRINOLOGY, 1983, 112 (01) :86-95
[7]   CLINICAL PHARMACOKINETICS OF ANTITHYROID DRUGS [J].
KAMPMANN, JP ;
HANSEN, JM .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :401-428
[8]  
LEE PW, 1978, DRUG METAB DISPOS, V6, P591
[9]   EXCRETION OF PROPYLTHIOURACIL AND ITS METABOLITES IN RAT BILE AND URINE [J].
LINDSAY, RH ;
HILL, JB ;
KELLY, K ;
VAUGHN, A .
ENDOCRINOLOGY, 1974, 94 (06) :1689-1698
[10]   SITE OF GLUCURONIDE CONJUGATION TO ANTITHYROID DRUG 6-NORMAL-PROPYL-2-THIOURACIL [J].
LINDSAY, RH ;
VAUGHN, A ;
KELLY, K ;
ABOULENEIN, HY .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (09) :833-840